About E3 ubiquitin-protein ligase TRIM38
E3 ubiquitin-protein ligase TRIM38 (TRIM38) is a protein
from Homo sapiens identified by UniProt accession
O00635, 465 residues long.
MolForge cross-references it against 0 known binders and
168 disease associations.
Target properties
| Protein name | E3 ubiquitin-protein ligase TRIM38 |
| UniProt accession | O00635 |
| Gene | TRIM38 |
| Organism | Homo sapiens |
| Length | 465 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (168)
Diseases linked to this target (Open Targets).
- hemoglobin measurement · score 0.34
- mean corpuscular hemoglobin · score 0.31
- HbA1c measurement · score 0.27
- urate measurement · score 0.26
- diastolic blood pressure · score 0.18
- pulse pressure measurement · score 0.17
- type 1 diabetes mellitus · score 0.16
- testosterone measurement · score 0.16
- systemic lupus erythematosus · score 0.15
- cognitive function measurement · score 0.14
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O00635-F1 | alphafold | PREDICTED | 87.30 | — |
Amino-acid sequence (465 residues)
MASTTSTKKM MEEATCSICL SLMTNPVSIN CGHSYCHLCI TDFFKNPSQK QLRQETFCCP QCRAPFHMDS LRPNKQLGSL IEALKETDQE MSCEEHGEQF HLFCEDEGQL ICWRCERAPQ HKGHTTALVE DVCQGYKEKL QKAVTKLKQL EDRCTEQKLS TAMRITKWKE KVQIQRQKIR SDFKNLQCFL HEEEKSYLWR LEKEEQQTLS RLRDYEAGLG LKSNELKSHI LELEEKCQGS AQKLLQNVND TLSRSWAVKL ETSEAVSLEL HTMCNVSKLY FDVKKMLRSH QVSVTLDPDT AHHELILSED RRQVTRGYTQ ENQDTSSRRF TAFPCVLGCE GFTSGRRYFE VDVGEGTGWD LGVCMENVQR GTGMKQEPQS GFWTLRLCKK KGYVALTSPP TSLHLHEQPL LVGIFLDYEA GVVSFYNGNT GCHIFTFPKA SFSDTLRPYF QVYQYSPLFL PPPGD
Explore E3 ubiquitin-protein ligase TRIM38 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets